Stocks Comparison
BioCorRx vs Concentra Group Holdings Parent: revenue, profit, margins and growth compared
BioCorRx brought in $797.2K of revenue in fiscal 2025, Concentra Group Holdings Parent $2.2B in fiscal 2025. Revenue changed by +10,301.1% at BioCorRx and +13.9% at Concentra Group Holdings Parent on the year before, so BioCorRx grew faster. BioCorRx kept -431.5% of its revenue as net profit, Concentra Group Holdings Parent 7.7%.
Side by side, latest fiscal year
| BICX | CON | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $797.2K | $2.2B |
| Revenue growth | +10,301.1% | +13.9% |
| Net income | -$3.4M | $166.4M |
| Net margin | -431.5% | 7.7% |
| Free cash flow | n/a | $197.1M |
| Free cash flow margin | n/a | 9.1% |
| Earnings per share (diluted) | -$0.19 | $1.30 |
| Cash | $139.4K | $79.9M |
| Debt | n/a | $1.6B |
| Price to earnings | n/a | 27.2 |
| Market value | $6M | $4.5B |
| Dividend yield | n/a | 0.71% |
| Rank by revenue in sector | #655 of 742 · Health care | #111 of 742 · Health care |
Over the years
Questions about BioCorRx and Concentra Group Holdings Parent
Which is bigger by revenue, BioCorRx or Concentra Group Holdings Parent?
Concentra Group Holdings Parent is bigger by revenue: $2.2B in fiscal 2025, against $797.2K for BioCorRx in fiscal 2025.
Which keeps more of its revenue as profit, BioCorRx or Concentra Group Holdings Parent?
BioCorRx had a net margin of -431.5% in fiscal 2025; Concentra Group Holdings Parent had 7.7% in fiscal 2025.
Which grew revenue faster, BioCorRx or Concentra Group Holdings Parent?
In their latest fiscal years revenue changed by +10,301.1% at BioCorRx and +13.9% at Concentra Group Holdings Parent.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.